 |
|
| Venture Capital Bio Life Sciences (page 1 of 20) |
|
-5AM-
Offices: Menlo Park, California & Waltham, Massachusetts
5AM Ventures is a $65 million seed and early-stage fund that is focused
on creating and building the next generation of leading biotechnology companies.
5AM works with entrepreneurs and scientists to help shape the strategic
mission of new start-ups (or spin-outs) and provides business, financial,
deal structuring, recruiting and other assistance in the company-building
process.
Offices: Edina, Minnesota
7 Health Ventures is a professional venture capital fund dedicated to investing
in Israeli and Israeli-related companies, developing healthcare technologies
and products. Their commitment to their entrepreneurs is for a long-term
partnership because they understand that building a successful company takes
time. They accompany their entrepreneurs with integrity, resourcefulness
and dedication.
Offices: Auburndale, Massachusetts
At 20/20, they have assembled a group of experts with a diverse range of
backgrounds who have developed a vision for healthcare in the year 2020.
This vision guides their strategy for developing and commercializing technologies
that they feel will accelerate the implementation of successful 'Personalized
Medicine' approaches. Their team approach relies on an efficient and strategic
use of time and resources.-Aberdare-
Offices: San Francisco, California
The Aberdare Ventures team are experienced venture investors and operators
of healthcare technology companies. Their investment focus is driven by
their years of experience growing biopharmaceutical product companies and
therapeutic medical device companies. They have plenty of experience leading
early-stage investments, but they are comfortable co-investing as well.
Aberdare is willing to participate in financings as small as $1 million.
Offices: Palo Alto, California; Boston, Massachusetts & London, England
Abingworth is a long-established venture capital firm specializing in unquoted
and life science biomedical companies. Abingworth is active on both sides
of the Atlantic and, in the past fifteen years, has backed more than 80
developing life science/medical businesses. The majority of these have gone
on to public offerings or have merged or been acquired by leading companies
in the industry.
Offices: San Francisco, California
Acacia Venture Partners specializes in solely in identifying and building
leading service businesses in the healthcare industry. They firmly believe
that industry focus is critical to creating long term value in healthcare.
Acacia's team of venture capital professionals has been investing in healthcare
since the early 1980's. They have developed a deep industry understanding
and a robust network of contact in the healthcare industry.
Offices: Hackensack, New Jersey
Accelerated Technologies Partners is an investment partnership that focuses
on medical devices and actively leverages a structured collaboration between
world-leading physicians, experienced operational management and dedicated
capital to produce superior returns and substantial clinical value. The
ATP strategy supports the acceleration of product development and lowers
market and execution risks,. -Accuitive-
Offices: Atlanta, Georgia; Newport Beach, California & Rochester, Minnesota
Accuitive Medical Ventures is a venture capital firm in business to finance
and help develop early and expansion stage medical device and technology
companies. AMV has established relationships with some of the industry's
leading institutions to offer emerging companies and investors the opportunity
to work with AMV in building unique new businesses and long-term shareholder
value.
Offices: The Netherlands
Aescap Venture is a new Venture Capital Company targeted at European biomedical
companies. Their added value is based on best of breed investment managers.
All with a proven track record and the ability to coach and stimulate entrepreneurs
in the creation and growth of their companies. Their aim is to accelerate
the creation of value in the companies they invest in.
Offices: Minneapolis, Minnesota
Affinity Capital Management invests in private, US-based health care companies.
Within health care, they focus on the medical device, biotech, health care
service and health care information technology sectors. They prefer
companies with proprietary technology that have the potential to achieve
and sustain leadership positions in large growing markets.
Offices: Montreal, Quebec
The principals at AgeChem have operational experience having been involved
in the launching of companies, their financing and in the management of
their growth and liquidity event. They also have expertise in various fields
of science (six members have a Ph.D.) covering biochemistry, chemistry,
immunology, oncology, virology, bacteriology and human genetics.-Aglaia-
Offices: The Netherlands
Aglaia identifies groundbreaking opportunities in cancer research and, in
close partnerships with inventors and entrepreneurs, takes these opportunities
to the next phase of technical and commercial development. Aglaia finds
themselves fortunate to be supported by some of the world’s foremost authorities
in cancer research and by experienced business people in the biomedical
field.
Offices: New York, New York
Aisling Capital Believes the next decade will be marked by a revolution
in healthcare driven by new therapeutics generated by biotechnology. The
completion of human genome has given scientists new insights into the cause
of human disease. These insights, combined with the past 20 years of developments
in the biotechnology industry, are leading to rapid expansion of novel approaches
toward the diagnosis, prevention, and treatment of life-threatening illnesses.
Offices: Berkeley, California & San Francisco, California
Alafi Capital is a private venture capital firm that has been active in
healthcare investing for over 25 years. Early and mid-stage investments
in the U.S. and Europe are considered, with emphasis on product-oriented
biotechnology, life science technologies, imaging and diagnostics, and medical
devices.
Offices: San Francisco, California
Alta Partners was founded in 1996 by four of the senior partners of Burr,
Egan, Deleage & Co. (BEDCO), a pioneering venture capital firm formed in
1979 Alta Partners is a leading venture capital firm in life sciences, funding
over 130 companies in the industry since 1996. Their diverse and integrated
team brings together a powerful depth of knowledge and experience, delivering
tangible results for their companies and their investors.
Offices: Thousand Oaks, California
As a company formed with venture capital funding more than 25 years ago,
Amgen understand the challenges faced by early-stage biotechnology companies.
In 2004, they announced the formation of Amgen Ventures, their corporate
venture capital fund. With an initial investment of $100 million, the fund
is designed to provide emerging biotechnology companies with resources to
develop pioneering discoveries focused on human therapeutics.
Print
(page 2)
Resources
to
top